Kangmei Pharma traded at 2.33 this Wednesday July 6th, decreasing 0.03 or 1.27 percent since the previous trading session. Looking back, over the last four weeks, Kangmei Pharma lost 9.34 percent. Over the last 12 months, its price fell by 21.55 percent. Looking ahead, we forecast Kangmei Pharma to be priced at 2.32 by the end of this quarter and at 2.13 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
2.31
Daily Change
-0.86%
Yearly
-22.22%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Hypermarcas 40.10 2.54 6.76% 16.77%
Genomma Lab Internacional 20.50 0.05 0.24% -0.15%

Indexes Price Day Year
SHANGHAI 3372 11.51 0.34% -4.34%

Kangmei Pharma
Kangmei Pharmaceutical Co., Ltd is a China-based company, principally engaged in the manufacture and sales of pharmaceutical products. The Company's principal products are Chinese medicines, including American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica and lonicera flower, among others. The Company is also engaged in the trading of Chinese herbal medicines, medical equipment and healthcare products related businesses. It also engages in the provision of real estate leasing and distribution services, among others. The Company mainly conducts its businesses within domestic markets.